Arkolith/Insider Trading/OVID/Form 4

Levin Jeremy M

CEO, DirectorOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Dec 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2023Gift(G)573K—$03.6M
Dec 4, 2023Gift(G)573K—$04.2M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057640) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML